Dignitana to participate in Redeye Medtech & Diagnostics Seminar on May 5

Files for download
Dignitana Release - wkr0006.pdf

Dignitana AB will participate in Redeye’s Medtech & Diagnostics Seminar on May 5, 2020, and at 09.35 CEO William Cronin will present the latest developments and the future for the company via link from Dallas, Texas.

The Redeye Medtech & Diagnostics Seminar is arranged for the third year and offers investors, analysts and the media the opportunity to listen to a number of exciting companies. The presentations are streamed live and can be viewed directly by clicking on the link http://play.redeye.se/live/medtech-diagnostics-5-maj

For More Information Contact

Investor Relations +1 469 518 5031 investorrelations@dignitana.com

About Dignitana

Dignitana AB is the world leader in clinically superior scalp cooling technology. The company produces The DigniCap® Scalp Cooling System, a patented medical cooling device that offers cancer patients the ability to minimize hair loss during chemotherapy. FDA cleared since 2015, DigniCap provides continuous cooling with high efficacy, safety and patient comfort. Hailed internationally as a life-changing medical advancement for cancer patients, The DigniCap Scalp Cooling System was invented in 1999 by a Swedish Oncology nurse and has been available in Europe since 2001.  Dignitana AB is listed on Nasdaq First North Growth Market in Sweden with headquarters in Lund, Sweden and operations based in Dallas, Texas in the United States.  Company subsidiaries are Dignitana, Inc. in the United States and Dignitana S.r.l. in Italy. Learn more at www.dignitana.se and www.dignicap.comEric Penser Bank AB, Certified Adviser, Box 7405,103 91 Stockholm Phone: +46 8-463 83 00 certifiedadviser@penser.se www.penser.se